SI
SI
discoversearch

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor.  We ask that you disable ad blocking while on Silicon Investor in the best interests of our community.  If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.
Biotech / Medical : Paracelsian Inc (PRLN)
 Public ReplyPrvt ReplyMark as Last ReadFilePrevious 10Next 10PreviousNext  
To: Harold Stone who wrote (2487)4/20/1997 9:39:00 PM
From: Hank   of 4342
 
Sure, the FDA probably isn't concerned with production. Just labelling. Someone said earlier that PRLN hadn't even selected a packaging scheme for AndroVir yet. Even if the FDA isn't breathing down PRLN's neck at this point, they have to be more than a little cautious about how they label the product. I anticipate a press release next week that announces a further delay in the AndroVir launch. Either way, I hope they announce something soon that clears up the mystery. This is more frustrating than a suspense novel.
Report TOU ViolationShare This Post
 Public ReplyPrvt ReplyMark as Last ReadFilePrevious 10Next 10PreviousNext  

HomeMailHotSubjectMarksPeopleMarksKeepersSettings
Terms Of UseContact UsCopyright/IP PolicyPrivacy PolicyAbout UsFAQAdvertise on SI
© 2026 Knight Sac Media.  Data provided by Twelve Data, Alpha Vantage, and CityFALCON News